quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:06:49·1707d
13D/GFiling
Taiwan Liposome Company, Ltd. logo

SEC Form SC 13D/A filed by Taiwan Liposome Company, Ltd. (Amendment)

TLC· Taiwan Liposome Company, Ltd.
Health Care
Original source

Companies

  • TLC
    Taiwan Liposome Company, Ltd.
    Health Care

Recent analyst ratings

  • Jul 13UpdateH.C. Wainwright$7.50
  • Jul 7UpdateLaidlaw-

Related

  • PR1411d
    TLC Announces TLC599 Agreement with Endo
  • PR1509d
    TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy
  • 13D/G1567d
    SEC Form SC 13D/A filed by Taiwan Liposome Company, Ltd. (Amendment)
  • 13D/G1624d
    SEC Form SC 13D/A filed by Taiwan Liposome Company, Ltd. (Amendment)
  • 13D/G1646d
    SEC Form SC 13D/A filed by Taiwan Liposome Company, Ltd. (Amendment)
  • SEC1652d
    SEC Form CB/A filed by Taiwan Liposome Company, Ltd. (Amendment)
  • SEC1658d
    SEC Form CB/A filed by Taiwan Liposome Company, Ltd. (Amendment)
  • SEC1658d
    SEC Form 6-K filed by Taiwan Liposome Company, Ltd.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022